---

Abingdon Health partners with companies from a variety of industries who require reader solutions for their lateral flow immunoassays. We are reader ‘agnostic’ in our approach and have worked with our customers’ preferred reader. If required we can customise our in-house reader solutions.

Partner with us if you are:

• looking for a data solution that can produce rapid quantitative diagnostic results
• wanting to increase the marketability of an existing lateral flow assay with a data solution
• looking for a partner who can offer both assay and reader development and manufacture
• wanting to take advantage of our regulatory, legal manufacturer and commercial services

Our promise

Abingdon Health supports our customer’s product and organisational ambitions by offering a flexible and value for money service that produce data solutions that streamline test analysis and result delivery in order to meet a variety of stakeholder needs and expectations.

Our approach to every project

Our service follows a simultaneous assay and reader or Smartphone development process in order to deliver the desired semi-quantitative or quantitative product to market. Each project follows a robust, tried-and-tested, new product development and design review process that draws on our many years of experience.

Lateral flow reader and Smartphone customisation process

Abingdon Health’s reader and assay development teams work closely with our clients to outline the necessary requirements concerning:

• assay format
• quantification
• connectivity
• user workflow
• functionality
• reading parameters
• any regulatory requirements

More detail about the overall development service can be viewed on our lateral flow assay development page.

Desktop and Smartphone lateral flow reader technology

The desktop and Smartphone lateral flow assay reader technologies on offer from Abingdon Health have been designed to give users the most appropriate features required for the analysis of complex lateral flow devices. Learn more about these intuitive reader technologies by clicking on one of the images below.

Case study

Abingdon Health has launched an own-brand quantitative rapid lateral flow test for haematology oncology. See how we utilised our in-house end-to-end expertise and infrastructure to launch this test in a regulated market on our Case Studies page.

Check Prices